Arabian International Healthcare Holding Company (TADAWUL: 9530)
Saudi Arabia
· Delayed Price · Currency is SAR 37.70
-0.10 (-0.26%)
Oct 16, 2024, 11:15 AM AST
Arabian International Healthcare Holding Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 765.06 | 806.92 | 642.67 | 618.54 | 818.69 | 697.03 |
| Revenue Growth (YoY) | 2.91% | 25.56% | 3.90% | -24.45% | 17.45% | - |
| Cost of Revenue | 576.45 | 616.89 | 488.51 | 475.02 | 620.31 | 525.69 |
| Gross Profit | 188.6 | 190.04 | 154.16 | 143.52 | 198.38 | 171.34 |
| Selling, General & Admin | 141.68 | 136.79 | 113.62 | 90.96 | 97.14 | 90.47 |
| Other Operating Expenses | -13.71 | -13.1 | -9.56 | -11 | -2.86 | -1.41 |
| Operating Expenses | 140.53 | 130.21 | 100.58 | 62.42 | 97.23 | 108.23 |
| Operating Income | 48.08 | 59.82 | 53.58 | 81.09 | 101.15 | 63.12 |
| Interest Expense | -38.46 | -36.16 | -18.51 | -13 | -22.16 | -25.62 |
| Interest & Investment Income | 6.52 | 5.1 | 0.72 | - | - | - |
| Earnings From Equity Investments | -2.87 | -2.04 | 7.79 | 11.5 | 8.16 | 19.23 |
| Currency Exchange Gain (Loss) | -0.52 | -0.52 | -0.81 | -0.11 | -1.36 | - |
| Other Non Operating Income (Expenses) | -0.36 | -0.4 | -0.05 | -0.37 | -0.56 | - |
| EBT Excluding Unusual Items | 12.39 | 25.8 | 42.71 | 79.11 | 85.22 | 56.73 |
| Impairment of Goodwill | -41.03 | -17.2 | - | - | - | - |
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.44 | - |
| Other Unusual Items | 71.45 | 45.32 | -6.12 | 14.63 | 34.13 | - |
| Pretax Income | 42.81 | 53.92 | 36.59 | 93.74 | 119.79 | 56.73 |
| Income Tax Expense | 12.72 | 11.57 | 10.89 | 11.42 | 24 | 15.6 |
| Earnings From Continuing Operations | 30.09 | 42.35 | 25.71 | 82.31 | 95.79 | 41.13 |
| Minority Interest in Earnings | -0.3 | -4.26 | -5.23 | - | - | - |
| Net Income | 29.79 | 38.09 | 20.47 | 82.31 | 95.79 | 41.13 |
| Net Income to Common | 29.79 | 38.09 | 20.47 | 82.31 | 95.79 | 41.13 |
| Net Income Growth | 68.94% | 86.03% | -75.13% | -14.07% | 132.90% | - |
| Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 1 | 0 |
| Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 1 | 0 |
| Shares Change (YoY) | -0.42% | -0.94% | -0.11% | 1430.22% | 2514.00% | - |
| EPS (Basic) | 1.51 | 1.92 | 1.02 | 4.12 | 73.29 | 822.57 |
| EPS (Diluted) | 1.51 | 1.92 | 1.02 | 4.12 | 73.29 | 822.57 |
| EPS Growth | 69.65% | 87.79% | -75.10% | -94.38% | -91.09% | - |
| Free Cash Flow | 19.72 | 4.21 | 57.49 | 129.11 | 221.48 | -24.39 |
| Free Cash Flow Per Share | 1.00 | 0.21 | 2.88 | 6.46 | 169.46 | -487.78 |
| Dividend Per Share | - | - | 1.000 | 3.000 | 4.100 | - |
| Dividend Growth | - | - | -66.67% | -26.83% | - | - |
| Gross Margin | 24.65% | 23.55% | 23.99% | 23.20% | 24.23% | 24.58% |
| Operating Margin | 6.28% | 7.41% | 8.34% | 13.11% | 12.35% | 9.06% |
| Profit Margin | 3.89% | 4.72% | 3.19% | 13.31% | 11.70% | 5.90% |
| Free Cash Flow Margin | 2.58% | 0.52% | 8.95% | 20.87% | 27.05% | -3.50% |
| EBITDA | 55.54 | 69.29 | 58.57 | 84.74 | 105 | 67.88 |
| EBITDA Margin | 7.26% | 8.59% | 9.11% | 13.70% | 12.83% | 9.74% |
| D&A For EBITDA | 7.47 | 9.47 | 4.99 | 3.65 | 3.85 | 4.76 |
| EBIT | 48.08 | 59.82 | 53.58 | 81.09 | 101.15 | 63.12 |
| EBIT Margin | 6.28% | 7.41% | 8.34% | 13.11% | 12.35% | 9.05% |
| Effective Tax Rate | 29.70% | 21.46% | 29.75% | 12.19% | 20.03% | 27.50% |
Source: S&P Capital IQ. Standard template. Financial Sources.